Literature DB >> 8319623

Exposure to aflatoxin B1 in animal-feed production plant workers.

J L Autrup1, J Schmidt, H Autrup.   

Abstract

The exposure to aflatoxin B1 (AFB) in animal-feed processing plants was assessed using binding of AFB to serum albumin. The albumin fraction was digested with pronase, and the digest was purified on a C18 Sepak column and an aflatest affinity column before quantification by ELISA. The level of detectability was 5 pg/mg albumin. The workers served as their own controls, as blood samples were taken upon return from vacation and after 4 weeks of work. A total of 7 of 45 samples were positive for AFB, with an estimated average daily intake of 64 ng AFB/kg body weight. The exposed workers had been disembarking cargos contaminated with AFB or working at places where the dust contained detectable amounts of AFB. The sera from the exposed workers had a significantly higher titer against an aflatoxin B1-epitope than a nonexposed Danish control group. The level of exposure could partly explain the increased risk of liver cancer in workers in the animal-feed processing industry.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8319623      PMCID: PMC1567032          DOI: 10.1289/ehp.9399195

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  12 in total

1.  Primary liver cancer and aflatoxin intake in Transkei.

Authors:  S J van Rensburg; G C van Schalkwyk; D J van Schalkwyk
Journal:  J Environ Pathol Toxicol Oncol       Date:  1990 Jan-Apr       Impact factor: 3.567

2.  Evaluation of methods for quantitation of aflatoxin-albumin adducts and their application to human exposure assessment.

Authors:  C P Wild; Y Z Jiang; G Sabbioni; B Chapot; R Montesano
Journal:  Cancer Res       Date:  1990-01-15       Impact factor: 12.701

3.  [Monoclonal antibody against aflatoxin B1 and its potential application].

Authors:  Z T Sun
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  1983-11

4.  Evidence for human antibodies that recognize an aflatoxin epitope in groups with high and low exposure to aflatoxins.

Authors:  H Autrup; T Seremet; J Wakhisi
Journal:  Arch Environ Health       Date:  1990 Jan-Feb

5.  Registry-based analysis of occupational risks for primary liver cancer in Sweden.

Authors:  J K McLaughlin; H S Malker; B K Malker; B J Stone; J L Ericsson; W J Blot; J A Weiner; J F Fraumeni
Journal:  Cancer Res       Date:  1987-01-01       Impact factor: 12.701

6.  Aflatoxin exposures in the industrial setting: an epidemiological study of mortality.

Authors:  R B Hayes; J P van Nieuwenhuize; J W Raatgever; F J ten Kate
Journal:  Food Chem Toxicol       Date:  1984-01       Impact factor: 6.023

7.  Reduction of intestinal carcinogen absorption by carcinogen-specific secretory immunity.

Authors:  L K Silbart; D F Keren
Journal:  Science       Date:  1989-03-17       Impact factor: 47.728

8.  Reduction of covalent binding of aflatoxin B1 to rabbit liver DNA after immunization against this carcinogen.

Authors:  M Caviezel; A P Aeschbach; W K Lutz; C Schlatter
Journal:  Arch Toxicol Suppl       Date:  1984

9.  Protection of mice against 7,12-dimethylbenz(a)anthracene-induced skin tumors by immunization with a fluorinated analog of the carcinogen.

Authors:  F L Moolten; B Schreiber; A Rizzone; A J Weiss; E Boger
Journal:  Cancer Res       Date:  1981-02       Impact factor: 12.701

10.  Radioimmunotherapy of transplanted small cell lung cancer with 131I-labelled monoclonal antibody.

Authors:  S Yoneda; M Fujisawa; J Watanabe; T Okabe; F Takaku; T Homma; K Yoshida
Journal:  Br J Cancer       Date:  1988-09       Impact factor: 7.640

View more
  7 in total

1.  One-step detection of aflatoxin-B(1) using scFv-alkaline phosphatase-fusion selected from human phage display antibody library.

Authors:  Kuntalee Rangnoi; Nanthnit Jaruseranee; Richard O'Kennedy; Potjamas Pansri; Montarop Yamabhai
Journal:  Mol Biotechnol       Date:  2011-11       Impact factor: 2.695

2.  The significance of mycotoxins in the framework of assessing workplace related risks.

Authors:  S Mayer; S Engelhart; A Kolk; H Blome
Journal:  Mycotoxin Res       Date:  2008-09       Impact factor: 3.833

Review 3.  Hepatocellular carcinoma and the risk of occupational exposure.

Authors:  Venerando Rapisarda; Carla Loreto; Michele Malaguarnera; Annalisa Ardiri; Maria Proiti; Giuseppe Rigano; Evelise Frazzetto; Maria Irene Ruggeri; Giulia Malaguarnera; Nicoletta Bertino; Mariano Malaguarnera; Vito Emanuele Catania; Isidoro Di Carlo; Adriana Toro; Emanuele Bertino; Dario Mangano; Gaetano Bertino
Journal:  World J Hepatol       Date:  2016-05-08

4.  Airborne mycotoxins in dust from grain elevators.

Authors:  S Mayer; V Curtui; E Usleber; M Gareis
Journal:  Mycotoxin Res       Date:  2007-06       Impact factor: 3.833

5.  Survey on Urinary Levels of Aflatoxins in Professionally Exposed Workers.

Authors:  Fulvio Ferri; Carlo Brera; Barbara De Santis; Giorgio Fedrizzi; Tiziana Bacci; Lorena Bedogni; Sauro Capanni; Giorgia Collini; Enrica Crespi; Francesca Debegnach; Patrizia Ferdenzi; Angelo Gargano; Daniela Gattei; Ferdinando Luberto; Ines Magnani; Massimo Giuseppe Magnani; Pamela Mancuso; Simonetta Menotta; Stefania Mozzanica; Milva Olmi; Giuseppe Ombrini; Orietta Sala; Sabina Soricelli; Massimo Vicentini; Paolo Giorgi Rossi
Journal:  Toxins (Basel)       Date:  2017-03-24       Impact factor: 4.546

Review 6.  Non‑infective occupational risk factors for hepatocellular carcinoma: A review (Review).

Authors:  Caterina Ledda; Carla Loreto; Christian Zammit; Andrea Marconi; Lucrezia Fago; Serena Matera; Valentina Costanzo; Giovanni Fuccio Sanzà; Stefano Palmucci; Margherita Ferrante; Chiara Costa; Concettina Fenga; Antonio Biondi; Cristoforo Pomara; Venerando Rapisarda
Journal:  Mol Med Rep       Date:  2016-12-14       Impact factor: 2.952

7.  Association between aflatoxin B1 occupational airway exposure and risk of hepatocellular carcinoma: a case-control study.

Authors:  Hao Lai; Xianwei Mo; Yang Yang; Ke He; Jun Xiao; Chao Liu; Jiansi Chen; Yuan Lin
Journal:  Tumour Biol       Date:  2014-06-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.